Skip to main content

Advertisement

Log in

Treatment of obesity with type 2 diabetes mellitus by trans-catheter left gastric artery embolization under the thermo-sensitive nano-gel vascular embolization agent

  • Original Article
  • Published:
Applied Nanoscience Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

This research aimed to investigate the efficacy of trans-catheter left gastric artery embolization (LGAE) in the treatment of obesity with type 2 diabetes mellitus (T2DM), and to compare the advantages of thermo-sensitive nano-gel as a vascular embolization agent. In this study, nine healthy adult male beagle dogs were randomly divided into three groups (three dogs in each group) to establish the model of obesity with type 2 diabetes mellitus: a was the general embolization group of type 2 diabetes mellitus, and the embolization group of polyvinyl alcohol drug granules (PVA) by transcatheter left gastric artery embolization; In group B, the embolic agent was replaced by (N- isopropylacrylamide -co- butyl methacrylate) (PIB) temperature-sensitive nano-gel. Group C and the control group were perfused with 12 mL normal saline in the left gastric artery via catheter. The results showed that when the reaction temperature of PIB nanogel was between 60 ℃ and 80 ℃, the particle size fluctuated between (200.59 ± 2.78) and (213.31 ± 1.09) nm, and the phase transition temperature was between 30.1 ℃ and 31.0 ℃. Serum insulin concentration in PIB nanogel group was (19.55 ± 0.2274)uLU/mL lower than that in PVA group (20.89 ± 0.1144)uLU/mL (P < 0.05) and higher than that in the control group (17.72 ± 0.1298)uLU/mL (P < 0.05). The insulin resistance index of the PIB nanogel group (7.260 ± 0.13) was lower than that of PVA group (12.57 ± 0.25) (P < 0.05) and higher than that of the control group (5.015 ± 0.17) (P < 0.05). In conclusion, the thermo-sensitive nano-gel was used as a new vessel embolization agent, and the application of left gastric artery embolization for Beagle dogs with T2DM was beneficial to lower blood sugar, improve insulin resistance, and regulate insulin levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

References

Download references

Acknowledgements

The Joint Fund of National Natural Science Foundation of China (No. U1603127).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Weixin Ren.

Ethics declarations

Conflict of interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cao, G., Gu, J., Zhang, H. et al. Treatment of obesity with type 2 diabetes mellitus by trans-catheter left gastric artery embolization under the thermo-sensitive nano-gel vascular embolization agent. Appl Nanosci 13, 3533–3541 (2023). https://doi.org/10.1007/s13204-022-02697-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13204-022-02697-y

Keywords

Navigation